Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+52Cutaneous Melanoma+24Malignant Laryngeal Neoplasm+24Malignant Bladder Neoplasm+20Malignant Esophageal Neoplasm+16Malignant Pancreatic Neoplasm+12Malignant Prostate Neoplasm+12Malignant Salivary Gland Neop…+12Malignant Kidney Neoplasm+8Malignant Mesothelioma+8Malignant Testicular Neoplasm+8Malignant Hypopharyngeal Neop…0Malignant Lung Neoplasm0Hodgkin Lymphoma-4Leukemia-4
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+52100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
22074
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
92
activityPercentile
40

ranking row 2594916

2=Cutaneous Melanoma+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5125
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
48
activityPercentile
24

ranking row 2594917

2=Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2935
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2594918

4=Malignant Bladder Neoplasm+2088Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8995
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
68
activityPercentile
48

ranking row 2594919

5=Malignant Esophageal Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10081
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
76
activityPercentile
60

ranking row 2594920

6=Malignant Pancreatic Neoplasm+1280Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
15776
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
88
activityPercentile
76

ranking row 2594921

6=Malignant Prostate Neoplasm+1280Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
29002
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2594923

6=Malignant Salivary Gland Neoplasm+1280Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
463
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
24
activityPercentile
12

ranking row 2594922

9=Malignant Kidney Neoplasm+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7640
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
64
activityPercentile
56

ranking row 2594925

9=Malignant Mesothelioma+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2010
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2594924

9=Malignant Testicular Neoplasm+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
357
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
12
activityPercentile
4

ranking row 2594926

12=Malignant Hypopharyngeal Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
298
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
8
activityPercentile
8

ranking row 2594928

12=Malignant Lung Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
89575
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2594927

14=Hodgkin Lymphoma-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
730
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
32
activityPercentile
36

ranking row 2594930

14=Leukemia-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12051
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
84
activityPercentile
88

ranking row 2594929

14=Malignant Penile Neoplasm-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
231
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
4

ranking row 2594932

14=Malignant Thyroid Gland Neoplasm-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
593
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
28
activityPercentile
32

ranking row 2594931

18=Malignant Gastric Neoplasm-832Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6958
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
56
activityPercentile
64

ranking row 2594933

18=Malignant Liver Neoplasm-832Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9832
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
72
activityPercentile
80

ranking row 2594934

18=Malignant Rectal Neoplasm-832Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4807
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
44
activityPercentile
52

ranking row 2594935

21=Malignant Central Nervous System Neoplasm-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7074
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
60
activityPercentile
72

ranking row 2594936

21=Non-Hodgkin Lymphoma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11056
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
80
activityPercentile
92

ranking row 2594937

23=Malignant Anal Neoplasm-1612Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
240
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
4
activityPercentile
20

ranking row 2594939

23=Multiple Myeloma-1612Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5472
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
52
activityPercentile
68

ranking row 2594938

25=Malignant Nasopharyngeal Neoplasm-244Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
432
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
20
activityPercentile
44

ranking row 2594940

26=Malignant Breast Neoplasm-800Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
362
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
16
activityPercentile
96

ranking row 2594941

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash e8e0eb71d64c1a84264f8822